BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27688436)

  • 1. Skin Hyperpigmentation in Indian Population: Insights and Best Practice.
    Nouveau S; Agrawal D; Kohli M; Bernerd F; Misra N; Nayak CS
    Indian J Dermatol; 2016; 61(5):487-95. PubMed ID: 27688436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Sunscreen in Melasma and Postinflammatory Hyperpigmentation.
    Fatima S; Braunberger T; Mohammad TF; Kohli I; Hamzavi IH
    Indian J Dermatol; 2020; 65(1):5-10. PubMed ID: 32029932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous interaction with visible light: What do we know?
    Cohen L; Brodsky MA; Zubair R; Kohli I; Hamzavi IH; Sadeghpour M
    J Am Acad Dermatol; 2023 Sep; 89(3):560-568. PubMed ID: 32289393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pigmentation disorders.
    Plensdorf S; Martinez J
    Am Fam Physician; 2009 Jan; 79(2):109-16. PubMed ID: 19178061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of systemic treatments for skin lightening.
    Juhasz MLW; Levin MK
    J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural ingredients for darker skin types: growing options for hyperpigmentation.
    Alexis AF; Blackcloud P
    J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
    Kang HY; Valerio L; Bahadoran P; Ortonne JP
    Am J Clin Dermatol; 2009; 10(4):251-60. PubMed ID: 19489658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of visible light on skin health: The role of antioxidants and free radical quenchers in skin protection.
    Lim HW; Kohli I; Ruvolo E; Kolbe L; Hamzavi IH
    J Am Acad Dermatol; 2022 Mar; 86(3S):S27-S37. PubMed ID: 34942294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pigmentation disorders in association with systemic diseases].
    Danescu S; Salavastru C; Tiplica GS; Fritz K
    Hautarzt; 2020 Dec; 71(12):932-943. PubMed ID: 33201325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for a well-balanced sunscreen to protect human skin from both Ultraviolet A and Ultraviolet B damage.
    Moyal D
    Indian J Dermatol Venereol Leprol; 2012 Jun; 78 Suppl 1():S24-30. PubMed ID: 22710110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catamenial Hyperpigmentation: A Review.
    Mobasher P; Foulad DP; Raffi J; Zachary C; Fackler N; Zohuri N; Juhasz M; Atanaskova Mesinkovska N
    J Clin Aesthet Dermatol; 2020 Jun; 13(6):18-21. PubMed ID: 32884614
    [No Abstract]   [Full Text] [Related]  

  • 13. Periorbital Hyperpigmentation: A Comprehensive Review.
    Sarkar R; Ranjan R; Garg S; Garg VK; Sonthalia S; Bansal S
    J Clin Aesthet Dermatol; 2016 Jan; 9(1):49-55. PubMed ID: 26962392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Established treatments of skin hypermelanoses.
    Nikolaou V; Stratigos AJ; Katsambas AD
    J Cosmet Dermatol; 2006 Dec; 5(4):303-8. PubMed ID: 17716250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation ‑ is there a case to be made?
    Roberts WE
    J Drugs Dermatol; 2015 Apr; 14(4):337-41. PubMed ID: 25844605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of unwanted pigment.
    Chance EW
    Facial Plast Surg; 2014 Feb; 30(1):16-25. PubMed ID: 24488633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice and Educational Gaps in Abnormal Pigmentation.
    Mohammad TF; Hamzavi IH
    Dermatol Clin; 2016 Jul; 34(3):291-301. PubMed ID: 27363886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical peeling in ethnic/dark skin.
    Roberts WE
    Dermatol Ther; 2004; 17(2):196-205. PubMed ID: 15113287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.